The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation

Ruth Lewis; Anne-Marie Bagnall; S. King; N. Woolacott; C. Forbes; L. Shirran; S. Duffy; J. Kleijnen; G. ter Riet; R. Riemsma

doi:10.3310/hta6140

The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation

Ruth Lewis
, Anne-Marie Bagnall
, S. King
, N. Woolacott
, C. Forbes
, L. Shirran
, S. Duffy
, J. Kleijnen
, G. ter Riet
, R. Riemsma

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

Iaith wreiddiol	Saesneg
Cyfnodolyn	Health Technology Assessment
Cyfrol	6
Rhif cyhoeddi	14
Dynodwyr Gwrthrych Digidol (DOIs)	https://doi.org/10.3310/hta6140
Statws	Cyhoeddwyd - Rhag 2002

NDC y CU

Mae’r allbwn hwn yn cyfrannu at y Nod(au) Datblygu Cynaliadwy canlynol

NDC 3 Iechyd a Llesiant Da

Mynediad at Ddogfen

10.3310/hta6140

Dyfynnu hyn

@article{10a4c09c8a6843989f177d9c0f778e8f,

title = "The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation",

author = "Ruth Lewis and Anne-Marie Bagnall and S. King and N. Woolacott and C. Forbes and L. Shirran and S. Duffy and J. Kleijnen and \{ter Riet\}, G. and R. Riemsma",

year = "2002",

month = dec,

doi = "10.3310/hta6140",

language = "English",

volume = "6",

journal = "Health Technology Assessment",

issn = "1366-5278",

publisher = "NIHR Journals Library",

number = "14",

}

TY - JOUR

T1 - The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer

T2 - a systematic review and economic evaluation

AU - Lewis, Ruth

AU - Bagnall, Anne-Marie

AU - King, S.

AU - Woolacott, N.

AU - Forbes, C.

AU - Shirran, L.

AU - Duffy, S.

AU - Kleijnen, J.

AU - ter Riet, G.

AU - Riemsma, R.

PY - 2002/12

Y1 - 2002/12

U2 - 10.3310/hta6140

DO - 10.3310/hta6140

M3 - Article

SN - 1366-5278

VL - 6

JO - Health Technology Assessment

JF - Health Technology Assessment

IS - 14

ER -